The Dialysis Encephalopathy Syndrome: Possible Aluminum Intoxication

New England Journal of Medicine

Volumn 294, Issue 4, 1976, Pages 184-188

  Alfrey, Allen C ^a   Legendre, Gary R ^a   Kaehny, William D ^a  

^a UNIVERSITY OF COLORADO HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM; ALUMINUM HYDROXIDE; EDETIC ACID; PHOSPHORIC ACID;

ADVERSE DRUG REACTION; BONE; BRAIN; BRAIN DISEASE; CLINICAL STUDY; DRUG DETERMINATION; HEMODIALYSIS; MAJOR CLINICAL STUDY; MUSCLE; ORAL DRUG ADMINISTRATION; THERAPY; UREMIA;

ALUMINUM; ALUMINUM HYDROXIDE; BONE AND BONES; BRAIN; BRAIN DISEASES; HUMAN; MUSCLES; RENAL DIALYSIS; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; SYNDROME; TIME FACTORS; UREMIA;

EID: 0017234506     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM197601222940402     Document Type: Article

References (18)

1. Rubini ME, Coburn JW, Massry SG, et al: Renal osteodystrophy: some therapeutic considerations relative to long-term dialysis and transplantation. Arch Intern Med 124: 663–669, 1969
2. Clarkson EM, Luck VA, Hynson WV, et al: The effect of aluminum hydroxide on calcium, phosphorus and aluminum balances, the serum parathyroid hormone concentration and the aluminum content of bone in patients with chronic renal failure. Clin Sci 43: 519–531, 1972
3. Berlyne GM, Ben-Ari J, Pest D, et al: Hyperaluminaemia from aluminum resins in renal failure. Lancet 2: 494–496, 1970
4. Parsons V, Davies C, Goode C, et al: Aluminum in bone from patients with renal failure. Br Med J 4: 273–275, 1971
5. Diehl H: Calcein, calmagite, and o,o dihydroxyazobenzene titrimetric. Colorimetric, Fluorometric Reagents for Calcium and Magnesium. Columbus, Ohio, G Frederick Smith Chemical Company, 1964, pp 1–4
6. Perry EF, Koirtyohann SR, Perry HM Jr: Determination of cadmium in blood and urine by graphite furnace atomic absorption spectrophotometry. Clin Chem 21: 626–629, 1975
7. Evenson MA, Warren BL: Determination of serum copper by atomic absorption, with use of the graphite cuvette. Clin Chem 21: 619–625, 1975
8. Fuchs C, Brasche M, Paschen K, et al: Aluminum-Bestimmung Im Serum Mit Flammenloser Atomabsorption. Clin Chim Acta 52: 71–80, 1974
9. Tipton IH, Cook MJ: Trace elements in human tissue. II. Adult subjects from the United States. Health Phys 9: 103–145, 1963
10. Alfrey achéal, Mishell JM, Burks J, et al: Syndrome of dyspraxia and multifocal seizures associated with chronic hemodialysis. Trans Am Soc Artif Intern Organs 18: 257–261, 1972
11. Barratt LJ, Lawrence JR: Dialysis-associated dementia. Aust NZ J Med 5: 62–65, 1975
12. Mahurkar SD, Dhar SK, Salta R, et al: Dialysis dementia. Lancet 1: 1412–1415, 1973
13. Rosenbek JC, McNeil MR, Lemme ML, et al: Speech and language findings in a chronic hemodialysis patient: a case report. J Speech Hear Disord 40: 245–252, 1975
14. Kopeloff LM, Barrera SE, Kopeloff N: Recurrent convulsive seizures in animals produced by immunologic and chemical means. Am J Psychiatry 98: 881–902, 1942
15. Klatzo I, Wiśniewski H, Streicher E: Experimental production of neurofibrillary degeneration. I. Light microscopic observations. J Neuropathol Exp Neurol 24: 187–199, 1965
16. Miller CA, Levine EM: Effects of aluminum salts on cultured neuro-blastoma cells. J Neurochem 22: 751–758, 1974
17. McLaughlin AIG, Kazantzis G, King E, et al: Pulmonary fibrosis and encephalopathy associated with the inhalation of aluminum dust. J Ind Med 19: 253–263, 1962
18. Crapper DR, Krishnan SS, Dalton AJ: Brain aluminum distribution in Alzheimer's disease and experimental neurofibrillary degeneration. Science 180: 511–513, 1973